The pathogenesis of primary biliary cirrhosis

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 6, 2009, Pages 413-423

  Solís Herruzo, José A ^a   Solis Munoz P ^a   Munoz Yague T ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Autoimmunity; Genetics; Pathogenesis; Primary biliary cirrhosis; Xenobiotics

Indexed keywords

CXCL9 CHEMOKINE; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PYRUVATE DEHYDROGENASE COMPLEX; TOLL LIKE RECEPTOR 4;

APOPTOSIS; B LYMPHOCYTE; BILE DUCT INJURY; CELL ACTIVITY; CELLULAR IMMUNITY; ENZYME ACTIVITY; HUMORAL IMMUNITY; INNATE IMMUNITY; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 70349929668     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082009000600007     Document Type: Review

References (203)

1. Scheuer P. Primary biliary cirrhosis. Proc Roy Soc Med 1967; 60: 1257-1260
2. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Wirchows Arch A 1978; 379: 103-112
3. Kita H, Matsumura S, He X-S, Ansari AA, Lian ZX, Van de Water J, et al. Quantitative and functional analysis of PDC-E2 specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109: 1231-1240 (Pubitemid 34496601)
4. Graham AM, Dollinger MM, Howie SE, Harrison DJ. Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol 1998; 10: 553-557
5. Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 2002; 22: 228-234 (Pubitemid 34846361)
6. Iwata M, Harada K, Kono N, Kaneko S, Kobayashi K, Nakanuma Y. Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 2000; 31: 179-184 (Pubitemid 30090646)
7. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25: 1077-1084 (Pubitemid 27199930)
8. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, Meyer zum Buschenfelde KH. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431: 119-124
9. Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 2001; 34: 500-506 (Pubitemid 32328505)
10. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 1997; 26: 1399-1405 (Pubitemid 27520002)
11. Harada K, Iwata M, Kono N, Koda W, Shimonishi T, Nakanuma Y. Distribution of apoptotic cells and expression of apoptosis related proteins along the intrahepatic biliary tree in normal and non-biliary diseased liver. Histopathology (Oxf) 2000; 37: 347-354 (Pubitemid 30781589)
12. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996; 429: 119-129 (Pubitemid 26378964)
13. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25: 1077-1084 (Pubitemid 27199930)
14. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001; 108: 223-232 (Pubitemid 32656246)
15. Zheng SJ, Wang P, Tsabary G, Chen YH. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 2004; 113: 58-64. (Pubitemid 38541632)
16. Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, et al. Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem 2004; 52: 821-831 (Pubitemid 38703137)
17. Higuchi H, Grambihler A, Canbay A Bronk SF, Gores GJ. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 2004; 279: 51-60. (Pubitemid 38044798)
18. Iwata M, Harada K, Kono N, Kaneko S, Kobayashi K, Nakanuma Y. Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 2000; 31: 179-184 (Pubitemid 30090646)
19. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123: 1031-1043
20. Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishiashi H, Coppel Rl, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102: 1831-1840 (Pubitemid 28533830)
21. Muntané J, Durán-Prado M, Rodríguez-Ariza A, Sánchez-Garrido MA, Collado JA, López-Sánchez LM, et al. Mechanisms of liver cell injury. Rev Esp Enferm Digest 2007; 99: 405-410
22. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7: 759-777
23. Mitchison H C, Bassendine M F, Hendrick A, Bennett MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 1986; 6: 1279-1284
24. Metcalf J V, Mitchison H C, Palmer J M, Jones D E, Bassendine M F, James O F. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-1402 (Pubitemid 26395233)
25. Prince M, Chetwynd A, Newman W, Metcalf JV, James OF. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002; 123: 1044-1051
26. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007; 45: 659-665 (Pubitemid 46450617)
27. Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis: a subsetof primary biliary cirrosis. Liver Internat 2008; 28: 233-239 (Pubitemid 351201037)
28. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7: 759-777
29. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273
30. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875-879
31. Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, et al. Evidence for the targeting by 2-oxodehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J. Immunol 1991; 146: 89-94.
32. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210-225 (Pubitemid 30201390)
33. Krams SM, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989; 9: 411-416 (Pubitemid 19074973)
34. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 199; 100: 822-833
35. Migliaccio C, Nishio A, Van de Water J, Ansari AA, Leung PS, Nakanuma Y, et al. Monoclonal antibodies to mitochondrial E2 components defines autoepitopes in primary biliary cirrhosis. J Immunol 1998; 127: 485-492 (Pubitemid 28519072)
36. Migliaccio C, Nishio A, Van De Water J, Ansari AA, Leung PS, Nakanuma Y, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis, J Immunol 1998; 161: 5157-5163 (Pubitemid 28519072)
37. Migliaccio C, Van De Water J, Ansari AA, Kaplan MM, Coppel RL, Lam KS, et al. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic, Hepatology 2001; 33: 792-801. (Pubitemid 32246626)
38. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995; 21: 1031-1037
39. Harada K, van de Water J, Leung PSC, Coppel R, Nakanuma Y, Gershwing ME. In situ nucleic acid hybridization of pyruvate deshydrogenasecomplex-E2 in primary biliary cirrhosis: pyruvate deshydrogenase-E2 messenger RNA is expressed in hepatocytes but not in biliary epithelial cells. Hepatology 1997; 25: 27-32.
40. Harada K, van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominante of the Th1 subset. Hepatology 1997; 25: 791-796
41. Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, Neville MC, et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005; 12: 107-114 (Pubitemid 40220641)
42. Travaglione S, Falzano L, Fabbri A, Stringaro A, Fais S, Fiorentini C. Epithelial cells and expression of the phagocytic marker CD68: scavenging of apoptotic bodies following Rho activation. Toxicol In Vitro 2002; 16: 405-411 (Pubitemid 34756431)
43. Macdonald P, Palmer J, Kirby JA, Jones DE. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin Exp Immunol 2004; 136: 559-567 (Pubitemid 38703693)
44. Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2006; 27: 232-241 (Pubitemid 46199127)
45. Matsumura S, Van De Water J, Kita H, Coppel RL, Tsuji T, Yamamoto K, et al. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis related proteases. Hepatology 2002; 35: 14-22. (Pubitemid 34032539)
46. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6: 6-12 . (Pubitemid 29051849)
47. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997; 185: 843-854 (Pubitemid 27119868)
48. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996; 93: 1624-1629 (Pubitemid 26075176)
49. Bellone M. Apoptosis, cross-presentation, and the fate of the antigen specific immune response. Apoptosis 2000; 5: 307-314 (Pubitemid 30822306)
50. Macdonald P, Palmer J, Kirby JA, Jones DE. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin Exp Immunol 2004; 136: 559-567 (Pubitemid 38703693)
51. Fussey SP, Bassendine MF, Fittes D, Turner IB, James OF, Yeaman SJ. The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin Sci (Lond) 1989; 77: 365-368 (Pubitemid 19237077)
52. Fukushima N, Nalbandian G, Van De Water J, White K, Ansari AA, Leung P, et al. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC, Hepatology 2002; 36: 1383-1392 (Pubitemid 35403529)
53. Malmborg AC, Shultz DB, Luton F, Mostov KE, Richly E, Leung PS, et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis, J Autoimmun 1998; 11: 573-580 (Pubitemid 28520217)
54. Teoh KL, Rowley MJ, Zafirakis H, Dickson ER, Wiesner RH, Gershwin ME, MacKay IR. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semiautomated assay. Hepatology 1994; 20: 1220-1224 (Pubitemid 24323569)
55. Teoh KL, Mackay IR, Rowley MJ, Fussey SP. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 1994; 19: 1029-1033
56. Masuda J, Omagari K, Ohba K, Hazama H, Kadokawa Y, Kinoshita H, et al. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sci 2003; 48: 932-938 (Pubitemid 36470215)
57. Matsumura S, Van De Water J, Leung P, Odin JA, Yamamoto K, Gores GJ, et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis, Hepatology 2004; 39: 1415-1422 (Pubitemid 38569064)
58. Nishio A, van de Water J, Leung PS, Joplin R, Neuberger JM, Lake J, et al. Comparative studies of antimitochondrial autoantibodies in sera and bilis in primary biliary cirrhosis. Hepatology 1997; 25: 1085-1089 (Pubitemid 27199931)
59. Bjorkland A, Loof L, Mendel-Hartvig I, Totterman TH. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes. J Immunol 1994; 153: 2750-2757 (Pubitemid 24278144)
60. Inamura K, Tsuji H, Nakamoto Y, Suzuki M, Kaneko S. Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis. Clin Exp Immunol 2006; 145: 93-100. (Pubitemid 43893937)
61. Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, et al. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 2003; 125: 1705-1713 (Pubitemid 37500435)
62. Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004; 172: 6444-6452 (Pubitemid 38621254)
63. Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, et al. Identification of HLA-A2-restricted CD8(p) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002; 195: 113-123 (Pubitemid 34074501)
64. Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995; 21: 995-1002.
65. Isse K, Harada K, Sato Y, Nakanuma Y. Characterization of biliary intra-epithelial lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and pathological conditions: numbers of CD4CD28- intra-epithelial lymphocytes are increased in primary biliary cirrhosis. Pathol Int 2006; 56: 17-24.
66. Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E, et al. Distinct costimulation dependent and independent autoreactive Tcell clones in primary biliary cirrhosis. Gastroenterology 2003; 125: 1379-1387 (Pubitemid 37409758)
67. Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 723-733
68. Jones DE, Palmer JM, Yeaman SJ, Bassendine MF, Diamond AG. T cell responses to natural human proteins in primary biliary cirrhosis. Clin Exp Immunol 1997; 107: 562-568
69. Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, et al. Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur J Clin Invest 2001; 31: 639-646 (Pubitemid 32642896)
70. Shigematsu H, Shimoda S, Nakamura M, Matsushita S, Nishimura Y, Sakamoto et al. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and crossrecognition among mitochondrial autoantigens. Hepatology 2000; 32: 901-909 (Pubitemid 30808412)
71. Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31: 1212-1216 (Pubitemid 30351280)
72. Namekawa T, Snyder MR, Yen JH Goehring BE, Leibson PJ, Weyand CM, et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165: 1138-1145 (Pubitemid 30484786)
73. Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: From phenotypes to genotypes. Springer Semin Immunopathol 1998; 20: 5-22. (Pubitemid 28502446)
74. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol 1998; 161: 1018-1025 (Pubitemid 28323570)
75. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 115-123
76. Martínez OM, Villanueva JC, Gershwin ME, Krams SM Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-119
77. Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 2005; 41: 1329-1338 (Pubitemid 40770286)
78. Lohr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Buschenfelde KH Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-166 (Pubitemid 24221774)
79. Sekiya H, Komatsu T, Isono E, Furukawa M, Matsushima S, Yamaguchi N, et al. Decrease in the prevalence of IL-4-producing CD4T cells in patients with advanced stage of primary biliary cirrhosis. Am J Gastroenterol 1999; 94: 3589-3594
80. Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N, et al. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 1999; 19: 422-427 (Pubitemid 30039110)
81. Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, et al. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 2000; 164: 3368-3376 (Pubitemid 30149003)
82. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188: 1413-1419 (Pubitemid 28489578)
83. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883 (Pubitemid 28141661)
84. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746-754 (Pubitemid 28096070)
85. Harada K, Tsuneyama K, Yasoshima M, Kanemori Y, Ohta H, Masuda S, et al. Type 1 and type 2 memory T cells imbalance shown by expression of intrahepatic chemokine receptors relates to pathogenesis of primary biliary cirrhosis. Hepatol Res 2002; 24: 290-299 (Pubitemid 35314586)
86. Harada K, Ozaki S, Sudo Y, Tsuneyama K, Ohta H, Nakanuma Y. Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathol Int 2003; 53: 8-17. (Pubitemid 36241200)
87. Kita H, Imawari M, Gershwin ME. Cellular immune response in primary biliary cirrhosis. Hepatol Res 2004; 28: 12-17 (Pubitemid 38145782)
88. Ohtsuka K, Iiai T, Watanabe H, Tanaka T, Miyasaka M, Sato K, et al. Similarities and differences between extrathymic T cells residing in mouse liver and intestine. Cell Immunol 1994; 153: 52-66. (Pubitemid 24071582)
89. Matsumura S, Kita H, He XS, Ansari AA, Lian ZX, Van De Water J, et al. Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis. Hepatology 2002; 36: 1125-1134 (Pubitemid 35253428)
90. Nishimoto H, Yamada G, Mizuno M, Tsuji T. Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis. Acta Med Okayama 1994; 48: 317-322
91. Van den Oord JJ, Sciot R, Desmet VJ. Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 1986; 3: 310-317 (Pubitemid 17227479)
92. Nakanuma Y. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis. Hepatology 1993; 18: 570-575 (Pubitemid 23259956)
93. Beagley KW, Husband AJ. Intraepithelial lymphocytes: origins, distribution, and function. Crit Rev Immunol 1998; 18:237-254
94. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562 (Pubitemid 38680433)
95. Fehervari Z, Sakaguchi S. CD4+Tregs and immune control, J Clin Invest 2004; 114: 1209-1217
96. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352 (Pubitemid 41716771)
97. Sakaguchi S, Setoguchi R, Yagi H, Nomura T. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 2006; 305: 51-66. (Pubitemid 47400264)
98. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116: 1713-1722 (Pubitemid 43911026)
99. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis, Hepatology 2006; 43: 729-737
100. Oertelt S, Lian Z-X, Cheng C-M, Chuang Y-H, Padgett KA, He X-S, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice. J Immunol 2006; 177: 1655-1660 (Pubitemid 44092501)
101. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996; 105: 254-259 (Pubitemid 26246942)
102. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998; 78: 89-100. (Pubitemid 28074312)
103. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005; 201:1061-1067
104. Prieto J, Qian C, García N, Díez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993; 105: 572-578 (Pubitemid 23213546)
105. Melero S, Spirli C, Zsembery A, Medina JF, Joplin RE, Duner E, et al. Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis. Hepatology 2002; 35: 1513-1521
106. Alper SL. Molecular physiology of SLC4 anion exchangers. Exp Physiol 2006; 91: 153-161
107. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001; 69: 522-530
108. Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I, et al. Ae2a,B-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008; 134: 1482-1493 (Pubitemid 351626951)
109. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4-9. (Pubitemid 27095892)
110. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002; 195: F9-F14. (Pubitemid 34461485)
111. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2: 957-964 (Pubitemid 37323216)
112. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
113. Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005; 42: 802-808 (Pubitemid 41401117)
114. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787 (Pubitemid 30671237)
115. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004; 34: 328-334 (Pubitemid 38748072)
116. Beutler B. TLR4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000; 12: 20-26 (Pubitemid 30093446)
117. Wang A-P, MigitaK, Ito M, Takii Y, Daikoku M, Yokoyama T, et al. Hepatic expression of toll-like receptor 4 in primar biliary cirrhosis Journal of Autoimmunity 2005; 25: 85-91.
118. Pasare C, Medzhitov R. Control of B-cell responses by toll-like receptors. Nature 2005; 438: 364-368 (Pubitemid 41643953)
119. Romics Jr L, Dolganiuc A, Kodys K, Drechsler Y, Oak S, Velayudham A, et al. Selective priming to toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Hepatology 2004; 40: 555-564 (Pubitemid 39265576)
120. Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 2003; 83: 1657-1667 (Pubitemid 37421106)
121. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, et al. In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNFalpha mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293
122. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce toll-like receptor 2 and toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001; 166: 2018-2024 (Pubitemid 32114690)
123. Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006; 203: 553-561
124. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002; 416: 603-607 (Pubitemid 34406754)
125. Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, et al. AMA Production in primary biliary cirrhosis is promoted by the TLR9 Ligand CpG and suppressed by potassium channel blockers. Hepatology 2007; 45: 314-322 (Pubitemid 46374588)
126. Kikuchi K, Lian ZX, Kimura Y, Selmi C, Yang GX, Gordon SC, et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005; 24: 347-352 (Pubitemid 40775859)
127. Kikuchi K, Lian ZX, Yang GX, Ansari AA, Ikehara S, Kaplan M, et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005; 128: 304-312 (Pubitemid 40431084)
128. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005; 42: 1194-1202 (Pubitemid 43112687)
129. Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N: Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006; 43: 525-531
130. Galperin C, Gershwin ME. Immunopathogenesis of gastrointestinal and hepatobiliary diseases. JAMA 1997; 278: 1946-1955
131. Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med 1997; 70: 403-408 (Pubitemid 28262255)
132. Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 1993; 17: 408-414 (Pubitemid 23134941)
133. Haydon GH, Neuberger J. PBC: an infectious disease? Gut 2000; 47: 586-588
134. Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 2001; 33: 530-536
135. Freudenberg MA, Galanos C. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. Int Rev Immunol 1990; 6: 207-221
136. Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1981; 1: 458-465 (Pubitemid 12218169)
137. Selmi C, Gershwin EM. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406-410 (Pubitemid 38803142)
138. Leung PS, Coppel RL, Gershwin ME. Etiology of primarybiliary cirrhosis: the search for the culprit. Semin Liver Dis 2005; 25: 327-336
139. Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 2002; 1: 37-42. (Pubitemid 38367423)
140. Kita H, He XS, Gershwin ME. Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis. Ann Med 2004; 36: 72-80. (Pubitemid 38230701)
141. Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004; 40: 31-39 (Pubitemid 38064710)
142. Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 2004; 39: 981-987 (Pubitemid 39388463)
143. Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand, Science 1991; 252: 1308-1310
144. Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005; 42: 458-465 (Pubitemid 41061099)
145. Haruta I, Kikuchi K, Hashimoto E, Kato H, Hirota K, Kobayashi M, et al. A possible role of histone-like DNA-binding protein of Streptococcus intermedius in the pathogenesis of bileduct damage in primary biliary cirrosis. Clinical Immunology 2008; 127: 245-251
146. Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, et al. Relation between Escherichia coli R (rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; ii: 1419-1422 (Pubitemid 20012059)
147. Klein R, Berg PA. Demostration of antibodies against the pyruvate dehydrogenase complex (M2) in sera from patients with tuberculosis. Hepatology 1992; 16: 556.
148. Johnson L, Wirostko E, Wirotsko W. Primary biliary cirrhosis in the mouse: induction by human micoplasma-like organism. Int J Exp Pathol 1990; 71: 701-712 (Pubitemid 20302437)
149. Bogdanos DP, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 2004; 22: 353-362 (Pubitemid 38543228)
150. Vilagut L, Vila J, Vinas O, Pares A, Gines A, Jimenez de Anta MT, Rodes J. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 1994; 21: 673-677 (Pubitemid 24324046)
151. Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumonie? J Hepatol 2004; 40: 380-384
152. Leung PS, Park O, Matsumura S, Ansari AA, Coppel RL, Gershwin ME. Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin Dev Immunol 2003; 10: 227-233
153. Liu H-Y, Deng A-M, Zhang J, Zhou Y, Yao D-K, Tu X-Q, et al. Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. World J Gastroenterol 2005; 11: 4108-4110 (Pubitemid 41235612)
154. Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38: 1250-1257 (Pubitemid 37314834)
155. Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 2147-2149
156. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrosis. Hepatology 2004; 39: 151-156 (Pubitemid 38461477)
157. Sutton I, Neuberger J. Primary biliary cirrhosis: seeking the silent partner of autoimmunity. Gut 2002; 50: 743-746 (Pubitemid 34539029)
158. Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM. Pilot studies of single and combination antiretroviral therapy in patientes with primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 2348-2355 (Pubitemid 40039364)
159. Perron H, Seigneurin JM. Human retroviral sequences associated with extracellular particles in autoimmune diseases: epiphenomenon or possible role in aetiopathogenesis? Microbes Infect 1999; 1: 309-322
160. Selmi C, Ross SR, Ansari AA, invernizzi P, Podda M, Coppel RL, Gershwing ME. Lack of immunobiological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004; 127: 493-501.
161. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174: 5874-5883 (Pubitemid 40593233)
162. Leung SA, Quan C, Van De Water J, Nantz MH, Kurth MJ, Barsky D, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167: 2956-2963 (Pubitemid 32768932)
163. Leung PS, Quan C, Park C, Van De Water J, Kurth MJ, Nantz MH, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003; 170: 5326-5332 (Pubitemid 36554768)
164. Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, et al. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 2003; 125: 1705-1713 (Pubitemid 37500435)
165. Leung PSC, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007; 179: 2651-2657
166. Jones DEJ, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003; 7: 841-864 (Pubitemid 37235935)
167. Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 2004; 53: 599-608. (Pubitemid 38372988)
168. Tanaka A, Borchers AT, Ishibashi H, Ansari AA, Keen CL, Gershwin ME. Genetic and familial considerations of primary biliary cirrhosis. Am J Gastroenterol 2001; 96: 8-15. (Pubitemid 32104801)
169. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999; 30: 402-407 (Pubitemid 29113227)
170. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47: 737-745
171. Jones DEJ, Watt FE, Metcalf JV, Bassendine MF, James OFW. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999; 30: 402-407 (Pubitemid 29113227)
172. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernezzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics and environment. Gastroenterology 2004; 127: 485-492 (Pubitemid 39091897)
173. Bach N, Schafner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20: 698-701.
174. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995; 36: 615-617
175. Lazaridis KN, Juran BD, Boe GM, Slusser JP, Andrade M, Homburger HA, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrosis. Hepatology 2007; 46: 785-792 (Pubitemid 47436125)
176. Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis is a welldefined cohort. Hepatology 2001; 34: 1083-1088 (Pubitemid 33096579)
177. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005; 175: 575-578 (Pubitemid 40894631)
178. Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME. Genes and (auto)immunity in primary biliary cirrosis. Genes Immun 2005; 6: 543-556 (Pubitemid 41637662)
179. Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ. Human leucocyte antigen class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J Hepatol 2002; 36: 8-13. (Pubitemid 34234010)
180. Donaldson PT, Baragiotta IB, Heneghan MA, Floreani A, Venturi C, Underhill JA et al. HLA Class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006; 44: 667-674 (Pubitemid 44433723)
181. Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008; 48: 1906-1912
182. Maeda T, Onishi S, Saibara T, Iwasaki S, Yamamoto Y. HLA DRw8 and primary biliary cirrhosis. Gastroenterology 1992; 103: 118-119
183. Seki T, Kiyosawa K, Ota M, Furuta S, Fukushima H, Tanaka E, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993; 18: 73-78 (Pubitemid 23193620)
184. Donaldson P, Agarwal K, Craggs A, Craig W, Jones D, James O. HLA and interleukin-1 gene polymorphisms in primary biliary cirrhosis; associations with disease progression and disease susceptibility. Gut 2001; 48: 397-402. (Pubitemid 32269570)
185. Invernizzi P, Battezzati PM, Crosignani A, Peregro F, Poli F, Morabito A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J. Hepatol 2003; 38: 401-406 (Pubitemid 36399240)
186. Donaldson, PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol 1999; 31: 366-368 (Pubitemid 29349767)
187. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48: 397-402. (Pubitemid 32269570)
188. Matsushita M, Tanaka A, Kikuchi K Kitazawa E, Kawaguchi N, Kawashima Y, et al. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity 2002; 35: 531-536 (Pubitemid 36321894)
189. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002; 35: 126-131 (Pubitemid 34032552)
190. Donaldson P, Veeramani S, Baragiotta A, Floreani A, Venturi C, Pearce S, et al. Cytototoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotype in primary biliary cirrosis. Clin Gastroenterol Hepatol 2007; 6: 755-760 (Pubitemid 46830049)
191. Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. Gastroenterology 2008; 135: 1200-1206
192. Scalapino KJ, Daikh DI. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 2008; 223: 143-155
193. Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, et al. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2004; 39: 779-791 (Pubitemid 38337658)
194. Kimura Y, Selmi C, Leung PS, Mao TK, Schauer J, Watnik M, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005; 41: 55-63. (Pubitemid 40066383)
195. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006; 27: 50-53 (Pubitemid 44279361)
196. Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118: 145-151 (Pubitemid 30020382)
197. Invernizzi P, Miozzo M, Battezzatti PM, Bianchi I, Grati FR, Simoni G, et al. The frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004; 363: 533-535 (Pubitemid 38229455)
198. Miozzo M, Selmi C, Gentilin B, Grati FR, Sirchia S, Oertelt S, et al. Prefential C chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007; 46: 456-462 (Pubitemid 47344781)
199. Elsheikh M, Wass J, Conway G. Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol (Oxf) 2001; 55: 223-226 (Pubitemid 32868587)
200. Milkiewicz P, Heathcote J: Primary biliary cirrhosis in a patient with Turner syndrome. Can J Gastroenterol 2005; 19: 631-633 (Pubitemid 41723289)
201. Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA, et al. Detection of male DNA in the liver of famele patients with primary biliary cirrhosis. J Hepatol 2000; 33: 690-695 (Pubitemid 30823699)
202. Tanaka A, Lindor K, Gish R, Batts K, Shiratori Y, Omata M, et al. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 1999; 30: 833-838 (Pubitemid 29458267)
203. Schoniger-Hekele M, Muller C, Ackermann J, Drach J, Wrba F, Penner E, et al. Lack of evidence for involvement of fetal microchimerism in patogenesis of primary biliary cirrhosis. Dig Dis Sci 2002; 47: 1909-1914 (Pubitemid 35024795)